Results 131 to 140 of about 1,452 (166)

A surrogate BSL2-compliant infection model recapitulating key aspects of human Marburg virus disease. [PDF]

Emerg Microbes Infect
Yang W, Zhou W, Liang B, Hu X, Wang S, Wang Z, Wang T, Xia X, Feng N, Zhao Y, Yan F.   +10 more
europepmc   +1 more source

Modeling and analysis using piecewise hybrid fractional operator in time scale measure for ebola virus epidemics under Mittag-Leffler kernel. [PDF]

Sci Rep
Naik PA, Farman M, Jamil K, Nisar KS, Hashmi MA, Huang Z.   +5 more
europepmc   +1 more source

Infection prevention and control studies for care of patients with suspected or confirmed filovirus disease in healthcare settings, with focus on Ebola and Marburg: an integrative review. [PDF]

BMJ Public Health
Frankfurter RG, Willet V, Richardson ET, Rutherford GW, Baller A, Kelly JD.   +5 more
europepmc   +1 more source

A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus. [PDF]

Elife
Zhang Y, Zhang M, Wu H, Wang X, Zheng H, Feng J, Wang J, Luo L, Xiao H, Qiao C, Li X, Zheng Y, Huang W, Wang Y, Wang Y, Shi Y, Feng J, Chen G.   +17 more
europepmc   +1 more source

Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses. [PDF]

Nat Commun
Meyer M, Gunn BM, Pietzsch C, Subramani C, Kedarinath K, Villarreal PP, Hyde MA, Saphire EO, Crowe JE, Alter G, Himansu S, Carfi A, Bukreyev A.   +12 more
europepmc   +1 more source

New reverse sum Revan indices for physicochemical and pharmacokinetic properties of anti-filovirus drugs. [PDF]

Front Chem
Tamilarasi W, Balamurugan BJ.
europepmc   +1 more source

Deep learning pipeline for accelerating virtual screening in drug discovery. [PDF]

Sci Rep
Noor F, Junaid M, Almalki AH, Almaghrabi M, Ghazanfar S, Tahir Ul Qamar M.   +5 more
europepmc   +1 more source

Detection of Bombali Virus in a <i>Mops condylurus</i> Bat in Kyela, Tanzania. [PDF]

Viruses
Düx A, Lwitiho SE, Ayouba A, Röthemeier C, Merkel K, Weiss S, Thaurignac G, Lander A, Kouadio L, Nowak K, Corman V, Drosten C, Couacy-Hymann E, Krüger DH, Kurth A, Calvignac-Spencer S, Peeters M, Ntinginya NE, Leendertz FH, Mangu C.   +19 more
europepmc   +1 more source

Kinetics of hematological and biochemical biomarkers are key tools for monitoring disease progression in Marburg virus-infected patients in Rwanda. [PDF]

Sci Rep
Mugisha JC, Kayigi E, Gahamanyi N, Uwayo HD, Umwanankabandi F, Gashema P, Rwagasore E, Turatsinze D, Nkeshimana M, Gashegu M, Ntagwabira E, Makayoto L, Ngabonziza JCS, Mukagatare I, Tuyishime A, Rujeni N, Mutesa L, Seruyange E, Musafiri S, Twagirumugabe T, Harelimana JD, Muvunyi CM.   +21 more
europepmc   +1 more source